- Home
- JSPR vs SMTI Comparison
JSPR vs SMTI Comparison
Compare JSPR & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- SMTI
- Stock Information
- Founded
- JSPR 2018
- SMTI 1982
- Country
- JSPR United States
- SMTI United States
- Employees
- JSPR N/A
- SMTI N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- SMTI Medical/Dental Instruments
- Sector
- JSPR Health Care
- SMTI Health Care
- Exchange
- JSPR Nasdaq
- SMTI Nasdaq
- Market Cap
- JSPR 321.8M
- SMTI 288.2M
- IPO Year
- JSPR N/A
- SMTI N/A
- Fundamental
- Price
- JSPR $21.03
- SMTI $32.96
- Analyst Decision
- JSPR Strong Buy
- SMTI Buy
- Analyst Count
- JSPR 11
- SMTI 1
- Target Price
- JSPR $73.38
- SMTI $44.00
- AVG Volume (30 Days)
- JSPR 174.0K
- SMTI 34.4K
- Earning Date
- JSPR 11-07-2024
- SMTI 11-12-2024
- Dividend Yield
- JSPR N/A
- SMTI N/A
- EPS Growth
- JSPR N/A
- SMTI N/A
- EPS
- JSPR N/A
- SMTI N/A
- Revenue
- JSPR N/A
- SMTI $78,056,873.00
- Revenue This Year
- JSPR N/A
- SMTI $29.95
- Revenue Next Year
- JSPR N/A
- SMTI $19.68
- P/E Ratio
- JSPR N/A
- SMTI N/A
- Revenue Growth
- JSPR N/A
- SMTI 24.66
- 52 Week Low
- JSPR $5.00
- SMTI $26.00
- 52 Week High
- JSPR $31.01
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- JSPR 45.81
- SMTI 42.59
- Support Level
- JSPR $19.41
- SMTI $33.08
- Resistance Level
- JSPR $23.11
- SMTI $37.44
- Average True Range (ATR)
- JSPR 1.83
- SMTI 1.65
- MACD
- JSPR -0.21
- SMTI -0.42
- Stochastic Oscillator
- JSPR 24.40
- SMTI 22.90
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.